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Abstract
Bovine mastitis is one of the most important bacterial diseases of dairy cattle 
throughout the world. Mastitis is responsible for great economic losses to the dairy 
producer and to the milk processing industry resulting from reduced milk produc-
tion, alterations in milk composition, discarded milk, increased replacement costs, 
extra labor, treatment costs, and veterinary services. Economic losses due to bovine 
mastitis are estimated to be $2 billion in the United States, $400 million in Canada 
(Canadian Bovine Mastitis and Milk Quality Research Network-CBMQRN) and 
$130 million in Australia per year. Many factors can influence the development of 
mastitis; however, inflammation of the mammary gland is usually a consequence of 
adhesion, invasion, and colonization of the mammary gland by one or more masti-
tis pathogens such as Staphylococcus aureus, Streptococcus uberis, and Escherichia coli.
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1. Introduction
Bovine mastitis is one of the most important bacterial diseases of dairy cattle 
throughout the world. Mastitis is responsible for major economic losses to the 
dairy producer and milk processing industry resulting from reduced milk produc-
tion, alterations in milk composition, discarded milk, increased replacement 
costs, extra labor, treatment costs, and veterinary services [1]. Annual economic 
losses due to bovine mastitis are estimated to be $2 billion in the United States [2], 
$400 million in Canada (Canadian Bovine Mastitis and Milk Quality Research 
Network-CBMQRN), and $130 million in Australia [3]. Many factors includ-
ing host, pathogen, and environmental factors influence the development of 
mastitis; however, inflammation of the mammary gland is usually a consequence 
of adhesion, invasion, and colonization of the mammary gland by one or more 
contagious (Staphylococcus aureus, Streptocococcus agalactiae, Corynebacterium 
bovis, Mycoplasmsa bovis, etc.) or environmental (coliform bacteria, environmental 
Streptococcus spp. and some coagulase negative Staphylococcus spp., many other 
minor pathogens) mastitis pathogens.
2. Etiology of mastitis
Over 135 various microorganisms have been identified from bovine mastitis. 
The most common bovine mastitis pathogens are classified as contagious and 
environmental mastitis pathogens [4]. This classification depends upon their 
distribution in their natural habitat and mode of transmission from their natural 
habitat to the mammary glands of dairy cows [5]. It is important to mention that all 
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pathogens lists as environmental or contagious may not be strictly environmental or 
strictly contagious; some of them may transmit both ways. Environmental mastitis 
pathogens exist in the cow’s environment, and they can cause infection at any time. 
Environmental mastitis pathogens are difficult to control because they are in the 
environment of dairy cows and can transmit to the mammary glands at any time, 
whereas contagious mastitis pathogens exist in the infected udder or on the teat skin 
and transmit from infected to non-infected udder during milking by milker’s hand 
or milking machine liners. Environmental mastitis pathogens include a wide range of 
organisms, including coliform bacteria (Escherichia coli, Klebsiella spp., Enterobacter 
spp., and Citrobacter spp), environmental Streptococcus spp. (Streptococcus uberis, 
Streptococcus dysgalactiae, Streptococcus equi, Streptococcus zooepidemicus, Streptococcus 
equinus, Streptococcus canis, Streptococcus parauberis, and others), Trueperella pyo-
genes, which was previously called Arcanobacterium pyogenes or Corynebacterium 
pyogenes and environmental coagulase-negative Staphylococcus species (CNS) (S. 
chromogenes, S. simulans, S. epidermidis, S. xylosus, S. haemolyticus, S. warneri, S. 
sciuri, S. lugdunensis, S. caprae, S. saccharolyticus, and others) [4, 6–9] and others such 
as Pseudomonas, Proteus, Serratia, Aerococcus, Listeria, Yeast and Prototheca that are 
increasingly found as mastitis-causing pathogens on some farms [10, 11].
Contagious mastitis pathogens primarily exist in the infected mammary glands 
or on the cow’s teat skin and transmit from infected to non-infected mammary 
glands during milking by milker’s hand or milking machine liners. Mycoplasma 
spp. may spread from cow to cow through aerosol transmission and invade the 
udder subsequent to bacteremia. The most frequent contagious mastitis pathogens 
are coagulase-positive Staphylococcus aureus, Streptococcus agalactiae, Mycoplasma 
bovis, and Corynebacterium bovis [11, 12]. The prevalence of mastitis caused by 
these different mastitis pathogens varies depending on herd management practices, 
geographical location, and other environmental conditions [13]. These differ-
ent causative agents of mastitis have a multitude of virulence factors that make 
 treatment and prevention of mastitis difficult.
2.1 Environmental mastitis pathogens
It is important to mention that all environmental mastitis pathogens may not be 
strictly environmental, and some of them may transmit both ways (contagious and 
environmental). However, the vast majority of these organisms are in the environ-
ment of dairy cows, and they transmit from these environmental sources to the 
udder of a cow at any time of the lactation cycle.
2.1.1 Streptococcus uberis mastitis
Streptococcus uberis is one of the environmental mastitis pathogens that accounts 
for a significant proportion of subclinical and clinical mastitis in lactating and non-
lactating cows and heifers [14]. This organism is commonly found in the bedding 
material, which facilitates infection of mammary glands at any time [15]. Some 
report also indicated the possibility of contagious transmission of Streptococcus 
uberis [16].
S. uberis has various mechanisms of virulence that increases the chances of this 
organism establishing infection. These include a capsule, which evades phagocy-
tosis, adherence to, and invasion into mammary epithelial cells [17, 18]. S. uberis 
adheres to epithelial cells using different mechanisms, including the formation of 
pedestals [19] and bridge formation through Streptococcus uberis adhesion molecule 
(SUAM) and lactoferrin [20–22]. This attachment is specific and mediated through 
a bridge formation between Streptococcus uberis adhesion molecule (SUAM) [23, 24] 
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on S. uberis surface and lactoferrin, which is in the mammary secretion and has 
a receptor on the mammary epithelial surface [20, 22]. This interaction creates 
a molecular bridge that enhances S. uberis adherence to and internalization into 
mammary epithelial cells most likely via caveolae-dependent endocytosis and 
potentially allows S. uberis to evade host defense mechanisms [22, 24]. These factors 
increase the pathogenicity of S. uberis to cause mastitis. The sua gene is conserved 
among strains of S. uberis isolated from geographically diverse areas [9, 13], and a 
sua deletion mutant of S. uberis is defective in adherence to and internalization into 
mammary epithelial cells [14].
2.1.2 Coagulase-negative Staphylococcus species (CNS)
More recently, coagulase-negative Staphylococcus species (CNS) such as  
S. chromogenes, S. simulans, S. xylosus, S. haemolyticus, S. hyicus, and S. epidermidis 
are increasingly isolated from bovine milk [7, 25–27] with S. chromogenes being the 
most increasingly diagnosed species as a cause of subclinical mastitis. Staphylococcus 
chromogenes [28] and other CNS [4, 8] have been shown to cause subclinical infec-
tions in dairy cows that reduce the prevalence of contagious mastitis pathogens.
Staphylococcus chromogenes is most commonly isolated from mammary secretions 
rather than from the environment itself [8, 29]. S. chromogenes consistently isolated 
from the cow’s udder and teat skin [30], and some studies showed that it causes 
long-lasting, persistent subclinical infections [26]. The CNS causes high somatic 
cell counts in milk on some dairy farms [29, 31]. Woodward et al. [32] evaluated 
the normal teat skin flora and found that 25% of the isolates exhibited the ability 
to prevent the growth of some mastitis pathogens. An in vitro study conducted on 
S. chromogenes showed that this organism could inhibit the growth of major mastitis-
causing pathogens such as Staph. aureus, Strep. dysgalactiae, and Strep. uberis [28]. 
In a study conducted on conventional and organic Canadian dairy farms, CNS were 
found in 20% of the clinical samples [33]. Recently, mastitis caused by CNS increas-
ingly became more problematic in dairy herds [30, 34–36]. However, mastitis caused 
by CNS is less severe compared to mastitis caused by Staphylococcus aureus [26].
2.1.3 Coliform mastitis
Coliform bacteria such as Escherichia, Klebsiella, and Enterobacter are a common 
cause of mastitis in dairy cows [37]. The most common species, isolated in more 
than 80% of cases of coliform mastitis, is Escherichia coli [38, 39]. E. coli usually 
infects the mammary glands during the dry period and progresses to inflammation 
and clinical mastitis during the early lactation with local and sometimes severe 
systemic clinical manifestations. Some reports indicated that the severity of E. coli 
mastitis is mainly determined by cow factors rather than by virulence factors of 
E. coli [40]. However, recent molecular and genetic studies showed that the patho-
genicity of E. coli is entirely dependent on the FecA protein that enables E. coli to 
actively uptake iron from ferric-citrate in the mammary gland [41]. The severity of 
the clinical mastitis and peak E. coli counts in mammary secretions are positively 
correlated. Intramammary infection with E. coli induced expression and release 
of pro-inflammatory cytokines [42, 43]. Recently, it has been shown with mouse 
mastitis models that IL-17A and Th17 cells are instrumental in the defense against 
E. coli intramammary infection [44, 45]. However, the role of IL-17 in bovine E. coli 
mastitis is not well defined. The result of recent vaccine efficacy study against E. coli 
mastitis suggested that cell-mediated immune response has more protective effect 
than humoral response [46]. However, the cytokine signaling pathways that lead to 
efficient bacterial clearance are not clearly defined.
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2.2 Contagious mastitis pathogens
2.2.1 Coagulase-positive Staphylococcus aureus
Coagulase-positive Staphylococcus aureus is one of the most common 
contagious mastitis pathogens in dairy cows, with an estimated incidence 
rate of 43–74% [47, 48]. Staphylococcus aureus is grouped under the family 
Staphylococcaceae and genus Staphylococcus. It is a gram-positive, catalase and 
coagulase-positive, non-spore forming, oxidase negative, non-motile, cluster-
forming, and facultative anaerobe [49]. The coagulase test is not an absolute 
test for the confirmation of the diagnosis of S. aureus from the cases of bovine 
mastitis, but more than 95% of all coagulase-positive staphylococci from bovine 
mastitis belong to S. aureus [50]. Other coagulase-positive species include 
S. aureus subsp. anaerobius causes lesion in sheep; S. pseudintermedius causes 
pyoderma, pustular dermatitis, pyometra, otitis externa, and other infections in 
dogs and cats; S. schleiferi subsp. coagulans causes otitis externa (inflammation of 
the external ear canal) in dogs; S. hyicus is coagulase variable (some strains are 
positive and some others are negative), species that causes mastitis in dairy cows, 
exudative epidermitis (greasy pig disease) in pigs; and S. delphini causes purulent 
cutaneous lesions in dolphins.
S. aureus can infect many host species, including humans. In humans, 
S. aureus causes a wide variety of illnesses ranging from mild skin infection to a 
life-threatening systemic infection. It has been reported that certain strains of 
S. aureus with specific tissue tropism can be adapted to infect specific tissue such as 
the mammary gland [51]. Furthermore, a study by McMillan [52] showed distinct 
lineages of S. aureus in bovine, ovine, and caprine species. S. aureus strains can be 
host specific, meaning that they are found more commonly in a specific species 
[51]. Some studies showed that S. aureus that causes mastitis belong to certain 
dominant clones, which are frequently responsible for clinical and subclinical 
mastitis in a herd at certain geographic areas, indicating that the control measures 
may need to be directed against specific clones in a given area [53–55]. However, 
because S. aureus is such a big problem in human health, cross-infection has been 
an important research topic. Several studies have reported cases of cross-infection 
in several different species [56–58]. In the dairy industry, there have been reports 
of human origin methicillin-resistant S. aureus infecting bovine mammary glands 
[59, 60]. These studies add to the unease that strains can gain new mutations 
or virulence factors and adapt to cross the interspecies boundary relatively 
rapidly [61].
Although the incidence of S. aureus mastitis can be reduced with hygienic 
milking practices and a good management system, it is still a major problem for 
dairy farms, with a prevalence of 66% among farms tested in the United States [62]. 
The prevalence of S. aureus mastitis varies from farm to farm because of variation 
in hygienic milking practices and overall farm management differences on the 
application of control measures for contagious mastitis pathogens. Good hygiene in 
the milking parlor can significantly reduce the occurrence of new S. aureus mastitis 
in the herd, but it does not remove existing cases within a herd [63]. Neave et al. 
concluded that it is nearly impractical to keep all udder quarters of dairy cows 
free of all pathogens at all times. Since this early observation by Neave et al. [63], 
many studies have confirmed that management practices can reduce new cases of 
intramammary infection (IMI) [9, 64] but cannot eliminate existing infections. In 
the United States, the prevalence of clinical and subclinical S. aureus mastitis ranged 
from 10 to 45% [65] and 15 to 75%, respectively.
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2.2.1.1 Virulence factors of S. aureus
Staphylococcus aureus has many virulence factors that can be grouped broadly 
into two major classes. These include (1) secretory factors which are surface 
localized structural components that serve as virulence factors and (2) secretory 
virulence factors which are produced by bacteria cells and secreted out of cells and 
act on different targets in the host body. Both non-secretory and secretory virulence 
factors together help this pathogen to evade the host’s defenses and colonize mam-
mary glands.
2.3 Non-secretory factors
Some of surface localized structural components that serve as virulence factors 
include membrane-bound proteins, which include collagen-binding protein, fibrino-
gen-binding protein, elastin-binding protein, penicillin-binding protein, and lipotei-
choic acid. Similarly, cell wall-bound factors such as peptidoglycan, lipoteichoic acid, 
teichoic acid, protein A, β-Lactamase, and proteases serve as non-secretory virulence 
factors. Other cell surface-associated virulence factors include exopolysaccharides, 
which comprises capsule, slime, and biofilm. Overall, S. aureus has over 24 surface 
proteins and 13 secreted proteins that are involved in immune evasion [66] and about 
15–26 proteins for biofilm formation [67, 68].
Surface proteins, such as staphylococcal protein A (SpA), clumping factors A 
and B (ClfA and ClfB) [69–71], fibrinogen-binding proteins [72], iron-regulated 
surface determinants (IsdA, IsdB, and IsdH) [69, 73], fibronectin-binding proteins 
A and B [74], biofilm associated protein (BAP) and exopolysaccharides (capsule, 
slime, and biofilms) [75–79], play roles in S. aureus adhesion to and invasion into 
host cells [80]. The BAP expression enhances biofilm production and the BAP gene 
is only found in S. aureus strain from bovine origin [81–83]. Evaluation of BAP 
gene of S. aureus from bovine and human isolates using polymerase chain reaction 
restriction fragment length polymorphism (PCR-RFLP) showed that bovine and 
human isolates are not closely related [84]. Thus, some host-specific evolutionary 
factors may have been developed between both strain types.
Biofilms are considered an important virulence factor in the pathogenesis of 
bovine S. aureus mastitis [77, 78]. Slime, an extracellular polysaccharide layer, acts 
as a barrier against phagocytosis and antimicrobials. It also helps with adhesion to 
a surface [85]. If a biofilm forms in a mammary gland, it will protect those bacteria 
from antimicrobials and the host’s immune system [77, 78]. In addition, once the 
biofilm matures and the immune attack has subsided, the biofilm can break open 
and allow reinfection of the mammary gland [86]. There are many contributors to 
biofilm production, such as polysaccharide intercellular adhesin (PIA) also known 
as poly-N-acetyl-β (1-6)-glucosamine (PNAG), MSCRAMMS, teichoic acids, and 
extracellular DNA (eDNA) [75, 76] that are known to help these bacteria cells to 
hold onto a surface [87]. Various proteins encoded by intercellular adhesion loci 
such as icaA, icaB, icaC, and icaD are involved in PIA production which in turn 
result in biofilm formation [75, 76]. Vasudevan et al. [88] evaluated the correlation 
of slime production and presence of the intercellular adhesion (ica) genes with 
biofilm production. These authors [88] found that all tested isolates were positive 
for icaA and icaD genes, and most tested isolates produce slime, but not all slime 
positives produced biofilms in vitro. Similarly, a study in Poland found that all iso-
lates were positive for icaA and icaD [80] genes. While adhesion is promoted with 
biofilm production, the bap gene prevents the invasion of host cells [83]. Despite 
the presence of the ica gene strongly support biofilm production, the presence of 
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the ica gene is not mandatory for biofilm production since S. aureus lacking ica gene 
can still produce biofilm through other microbial surface components recognizing 
adhesive matrix molecules (MSCRAM) and secreted proteins [89, 90].
2.4 Secretory factors
Some of the known secretory virulence factors are toxins which include staphy-
lococcal enterotoxins, non-enteric exfoliative toxins, toxic shock syndrome toxin 
1, leucocidin, and hemolysins (alpha, beta, delta, and gamma) [91, 92]. Similarly, 
enzymes such as coagulase, staphylokinase, DNAase, phosphatase, lipase, phospho-
lipase, and hyaluronidase serve as virulence factors of S. aureus [93].
2.4.1 Hemolysins
S. aureus isolates from bovine mastitis produce alpha (α), beta (β), gamma (γ), 
and delta (δ) hemolysins that cause hemolysis of red blood cells of the host [94] 
and all are antigenically distinct. α-hemolysin is a pore-forming toxin that binds 
to a disintegrin and metalloproteinase domain-containing protein-10 (ADAM10) 
receptor resulting in pore formation and cellular necrosis [95, 96]. It is also known 
to increase the inflammatory response and decrease macrophage function [97]. 
α-hemolysin damages the plasma membrane of the epithelial cell resulting in 
leakages of low-molecular-weight molecules from the cytosol and death of the cell 
[98]. It is produced by 20–50% of strains from bovine IMI [99]. A study reported 
that the α-hemolysin might be required for a cell to cell interaction during biofilm 
formation [100]. β-hemolysin hydrolyzes the sphingomyelin present in the plasma 
membrane resulting in increased permeability with progressive loss of cell surface 
charge [101]. It is produced by 75–100% of S. aureus strains from bovine IMI [99]. 
α-hemolysin expression requires specific growth conditions in vitro because its 
growth is inhibited by agar [102]. α-hemolysin producing strains cause complete 
hemolysis of sheep red blood cells, whereas β-hemolysin producing strains cause 
partial hemolysis within 24 h of incubation at 37°C [103]. Partial hemolysis caused 
by β-hemolysin becomes completely lysed after further storage at 4–15°C, which is 
also expressed as hot-cold lysis [104]. β-hemolysin producing strains are the most 
frequent isolates from animals [105]. δ-hemolysin causes complete hemolysis of 
red blood cells of wide range of species including human, rabbit, sheep, horse, rat, 
guinea pig, and some fish erythrocytes. δ-hemolysin migrates more slowly through 
agar than the α-hemolysin so the effect takes longer time to express. Double (α- and 
β-) hemolysin producing strains caused complete hemolysis in the middle with 
partial hemolysis on the peripheral area around each colony [105]. γ-hemolysin is 
produced by almost every strain of S. aureus, but γ-hemolysin is not identifiable on 
blood agar plates, due to the inhibitory effect of agar on toxin activity [106].
2.4.2 Enterotoxins Enterotoxins
These toxins are heat stable and can resist pasteurization. S. aureus produces 
staphylococcal enterotoxins A, B, C, D, E, G, H, I, and J–Q as well as toxic shock 
syndrome toxin 1 (tsst-1) [105, 107, 108]. Enterotoxins can get into the food 
chain through the consumption of contaminated food and cause food poisoning 
[109]. Staphylococcal enterotoxins tend to contaminate dairy products and cause 
foodborne illness [110, 111]. Staphylococcal enterotoxins G to Q (SEG–SEQ ) are 
prevalent among S. aureus isolates from cases of bovine mastitis and are also impli-
cated in the pathogenesis of mastitis. Some of these toxins are known to function as 
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superantigens that cause increased immunological reactivity in the host [110]. Some 
studies showed that about 20% of S. aureus isolates from IMI produce toxic shock 
syndrome toxin-1 [109, 112]. Toxic shock syndrome toxin causes toxic shock syn-
drome and can be fatal [113]. Besides the superantigenic effect of enterotoxins, their 
role in the pathogenesis of mastitis is unknown. It may be specific to each strain or 
area based on selective pressures in the habitat [114]. Enterotoxin prevalence seems 
to vary between geographical regions. The strains producing enterotoxin C have 
been isolated relatively frequently from cases of bovine mastitis [108, 115, 116].
Enterotoxins are believed to have a role in the development of mastitis since S. 
aureus isolates from cases of mastitis had a high prevalence of enterotoxins than iso-
lates from milk of cows without mastitis [117, 118]; however, staphylococcal entero-
toxins expressions are controlled by several regulatory elements [119] that respond 
to a variety of different micro-environmental stimuli and the exact mechanisms by 
which enterotoxins contribute to the development of mastitis are not clearly known 
and yet to be determined.
In addition to specific virulence factors, Staphylococcus aureus also possesses dif-
ferent mechanisms or traits such as biofilm formation, adhesion to and invasion into 
mammary epithelial cells, and formation of small colony variant (SCV) that enable 
this pathogen to resist host defense mechanisms. The ability of S. aureus to invade 
mammary epithelial cells during mastitis plays a significant role in the pathogenesis 
of S. aureus. Internalized bacteria can hide from the host’s immune system inside 
the host cell and continue to multiply inside the host cell [120]. There may be many 
mechanisms that S. aureus uses to invade into host cells, and each mechanism can 
be strain dependent. S. aureus strains have a fibronectin-binding protein that can 
link to the fibronectin on the mammary epithelial cell surface. Fibronectin bind-
ing protein is thought to be a common way for the bacteria cells to invade bovine 
mammary epithelial cells. Fibronectin-binding protein-deficient strains cannot 
invade host cells [121]. The presence of a capsule prevents adherence to epithelial 
cells [122, 123].
Adhesion is the first step in the formation of biofilm or the invasion of host 
cells, which protects the bacteria from the host immune system and facilitates 
chronic infection [124]. Adhesion is dependent on surface proteins called adhesins, 
which help the bacterium to recognize and attach to host cells. Staphylococci are 
coated with a wide variety of surface proteins that help them to adhere to host cells 
and extracellular matrix components. Microbial surface components recognizing 
adhesive matrix molecules (MSCRAMMs) of the host are the most common surface 
proteins that are involved in adhesion [124]. The ability to bind to host tissue or the 
host’s cell surface is a pivotal part of the bacteria’s pathogenicity because adhesion is 
typically the first step in the invasion and biofilm formation [125, 126].
Adhesion to and invasion into epithelial cells [124], intracellular survival 
in macrophages [127], and epithelial cells allow them to avoid detection by the 
host immune system and resist treatment with antibiotics [120]. Due to its poor 
response to treatments, S. aureus infections often become chronic with a low 
cure rate [128]. Treatment of Staphylococcus aureus mastitis with cloxacillin cured 
only 25% of the clinical cases and 40% of subclinical cases in the study by Tyler 
and Baggot [129]. Staphylococcus aureus also has a known ability to form biofilms 
[77, 78, 86] and acquire antimicrobial-resistance genes via horizontal resistance 
gene transfer, which enables this bacterium to develop antimicrobial resistance 
[130, 131].
The mode of transmission from infected mammary glands or colonized udder 
skin to healthy mammary glands is through contact during milking procedures with 
milker’s hand, towel, and milking machine [58]. S. aureus usually causes subclinical 
or chronic infections and is difficult to clear with antibiotic treatment [132].
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2.4.3 Streptococcus agalactiae
The most important virulence factor of S. agalactiae is the capsular polysaccha-
ride [133], which protects this bacterium from being engulfed by macrophages and 
subsequently phagocytosed [133]. Another virulence factor of S. agalactiae is the 
Rib protein, which confers resistance to proteases. Emaneini et al. [133] found that 
the Rib encoding gene (rib) was detected in 89% of the isolates from bovine origin. 
Streptococcus agalactiae causes persistent infections that are usually difficult to clear 
without antibiotic treatment [134]. Though Streptococcus agalactiae is highly conta-
gious, it has good response to treatment with antibiotics, which makes it possible to 
eliminate from herds with current mastitis control measures [129]. Since the adop-
tion of hygienic milking practices, the incidence of mastitis caused by S. agalactiae 
has dramatically decreased and is now rarely observed in dairy herds [135].
2.4.4 Mycoplasma mastitis
Mastitis caused by Mycoplasma spp. is a growing concern in the United States. It 
is believed that this organism has been underreported due to the difficulty of isola-
tion by culture method [136]. The incidence of Mycoplasma mastitis varies across 
the globe, with a 3.2% prevalence rate in the United States that may increase to 
14.4% in larger herd size of greater than 500 cows [47, 48, 62, 137]. A risk factor for 
Mycoplasma mastitis increase with herd size, and most of the Mycoplasma mastitis 
cases are subclinical infections with outbreaks linked to asymptomatic carriers 
[138]. Pathogenesis of most Mycoplasma spp. infection is characterized by adher-
ence to and internalization into host cells resulting in colonization of the host with 
immune modulation without causing severe disease [138]. Mycoplasma species lack 
a cell wall, thus not sensitive to beta-lactam antibiotics, but showed sensitivity to 
non-beta-lactam antibiotics [139].
3. Routes of entry of mastitis pathogens to the udder
In general, it is believed that mastitis pathogens gain entrance to the udder 
through teat opening into the teat canal and from the teat canal into the intramam-
mary area during the reverse flow of milk due to vacuum pressure fluctuation of 
the milking machine [9]. However, the detailed mechanism of mastitis pathogen 
colonization of the mammary gland may vary among species of bacteria and the 
virulence factors associated with particular strain in each species. An example 
of this is in some cases; it has been shown that E. coli can penetrate the teat canal 
without the reverse flow of milk [9]. Some of the major mastitis pathogens, such 
as E. coli [140], Staphylococcus aureus, and Streptococcus uberis [20–22] can adhere 
to and subsequently invade into the mammary epithelial cells. This adherence and 
subsequent invasion into mammary epithelial cells allow them to persist in the 
intracellular area as well as to escape the host immune defenses attack and action 
of antimicrobial drugs [120, 140–144]. Dogan et al. [145] compared E. coli strains 
known to cause chronic infections with strains known to cause acute infections and 
found that chronic strains were more invasive to the epithelial cells, leading to the 
difficulty in clearance and persistent infection compared to acute strains. S. aureus 
enters the mammary gland through the teat opening and subsequently multiply in 
the mammary gland where they may form biofilms, attach to, and internalize into 
the mammary epithelial cells causing inflammation of mammary glands charac-
terized by swelling, degeneration of epithelial cells, and epithelial erosions and 
ulcers [146, 147].
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4. Clinical manifestation of mastitis
Depending on clinical signs, mastitis can also be divided into clinical and 
subclinical mastitis. Clinical mastitis is characterized by visible inflammatory 
changes (abnormalities) in the mammary gland tissue such as redness, swelling, 
pain, increased heart, and abnormal changes in milk color (watery, bloody, and 
blood tinged) and consistency (clots or flakes) [9]. Clinical mastitis can be acute, 
peracute, subacute, or chronic. Acute mastitis is a very rapid inflammatory response 
characterized by systemic clinical signs which include fever, anorexia, shock, as well 
as local inflammatory changes in the mammary gland and milk. Peracute mastitis is 
manifested by a rapid onset of severe inflammation, pain, and systemic symptoms 
that resulted in a severely sick cow within a short period of time. Subacute mastitis 
is the most frequently seen form of clinical mastitis characterized by few local signs 
of mild inflammation in the udder and visible changes in milk such as small clots. 
Chronic mastitis is a long-term recurring, persistent case of mastitis that may show 
few symptoms of mastitis between repeated occasional flare-ups of the disease 
where signs are visible and can continue over periods of several months. Chronic 
mastitis often leads to irreversible damage to the udder from the repeated occur-
rences of the inflammation, and often these cows are culled.
Subclinical mastitis is the inflammation of the mammary gland that does not 
create visible changes in the milk or the udder. Subclinical mastitis is an infection 
of mammary gland characterized by non-visible inflammatory changes such as a 
high somatic cell count coupled with shedding of causative bacteria through milk 
[9]. During this inflammatory process, the milk samples showed a rapid increase 
of somatic cells, characterized by increased number of neutrophils in the secretion 
[146, 148]. Despite increased recruitment of somatic cells into infected mammary 
glands, evidenced by an increased number of neutrophils, infection usually does 
not clear but became subclinical. Intramammary infections during early lacta-
tion may become acute clinical mastitis characterized by gangrene development 
due congestion and thrombosis (blockage) of blood supply to the tissue but most 
new infection during late lactation or dry period become acute or chronic mastitis 
[149, 150].
The increase in somatic cell count during subclinical infections leads to a 
decrease in useful components in the milk, such as lactose and casein [151]. Lactose 
is the sugar found in milk, and casein is one of the major proteins in milk and 
decreases in these two components affect the quality and quantity of milk yield [9]. 
During mastitis, there is an increase in lipase and plasmin, which have a detrimental 
effect on the quantity and quality of milk due to the breakdown of milk fat and 
casein [9]. Subclinical infections can reduce milk production by 10–12% when just 
one-quarter is infected [152]. These subclinical infections cause some of the greatest 
unseen economic [20] losses because of their detrimental impact on production and 
milk quality without showing visible signs of infection [152].
5. Risk factors for mastitis
There are host-, pathogen-, and environmental-related risk factors that pre-
dispose dairy cows to mastitis. The host risk factors include age (parity), stage of 
lactation, somatic cell count, breed, the anatomy of the mammary glands/morphol-
ogy of udder and teat (diameter of teat canal and conformation of the udder), 
and immune competence (immunity) [153] (Figure 1). The environmental risk 
factors include the proper functioning status of milking machine, udder trauma, 
sanitation, climate, nutrition, management, season, and housing condition [154] 
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(Figure 1). The pathogen risk factors include type (bacteria, fungi, yeast, and 
algae), number (large number and small number), virulence (highly, moderate, or 
less virulent), frequency of exposure (dirty farm floor, dirty milking machine, and 
dirty teat drying towels frequently expose to pathogen; clean floor, clean milking 
machine, and clean teat drying towels less exposure to pathogens), ability to resist 
flushing out of the glands by milk (ability to adhere or attach to and invade or 
internalize into mammary epithelial cells), zoonotic (transmit from cow to human 
or vice versa) potential, and resistance to antimicrobials [4] (Figure 1). The warm, 
humid, and moist climate favors the growth of bacteria and increases the chances 
of intramammary infection (IMI) and mastitis development [154]. The incidence 
of mastitis varies from farm to farm due to the combined effects of these different 
factors that increase the risk of disease development.
Dairy cows are highly susceptible to IMI during the early dry period due to 
increased colonization of teat skin with bacteria. Bacterial colonization of teat 
increases during the early dry period because of an absence of hygienic milking 
practices including pre-milking washing and drying of teats [155], as well as pre- 
and post-milking teat dipping in antiseptic solutions [156, 157] that are known 
to reduce teat end colonization and infection. An udder infected during the early 
dry period usually manifests clinical mastitis during the transition period because 
of increased production of parturition inducing immunosuppressive hormones 
[158, 159], negative energy balance [160], and physical stress during calving [161].
6. Role of mastitis on public health
Mastitis is increasingly becoming a public health concern due to the ability of 
the causative bacterial pathogens and/or their products, such as enterotoxins, to 
Figure 1. 
Risk factors for mastitis. SA, Staphylococcus aureus; EC, Escherichia coli; SU, Streptococcus uberis; SCC, 
somatic cell count; AMR, antimicrobial resistance.
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enter the food supply and cause foodborne diseases [109, 162], especially through 
the consumption of raw milk [29] and undercooked meat of culled dairy cows 
due to chronic mastitis that are usually sold to the slaughter (abattoir) for meat 
consumption. The Center for Disease Control (CDC) estimated that roughly 48 
million people in the United States a year become sick from foodborne diseases 
[163]. Foodborne pathogens have been detected in bulk tank milk in multiple 
studies [164–167]. These authors found that the number of foodborne pathogens 
detected in bulk tank milk vary with location, management practices, hygiene, and 
number of animals on the farm [165]. Similarly, a study on bulk tank milk from 
east Tennessee and southwest Virginia by Rohrbach et al. [168] showed that 32.5% 
of the samples analyzed contained one or more foodborne pathogens. Even dairy 
producers who used proper hygienic milking practices, pre- and post-milking teat 
disinfectant and antibiotic dry cow therapy, had foodborne pathogens in their bulk 
tank milk [164]. The isolation of these foodborne pathogens from bulk tank milk 
samples across the United States demonstrate the threat that mastitis pathogens and 
zoonotic mastitis causing pathogens create on public health if raw milk is consumed 
or if these pathogens make it through processing.
7. Conclusions
Bovine mastitis is the most important multifactorial disease of dairy cattle 
throughout the world. Mastitis is responsible for huge economic losses to the dairy 
producers and milk processing industry due to reduced milk production, alterations 
in milk composition, discarded milk, increased replacement costs, extra labor, 
treatment costs, and veterinary services. Many factors including pathogen, host, 
and environment can influence the development of mastitis. Mastitis, the inflam-
mation of the mammary gland is usually a consequence of adhesion, invasion, and 
colonization of the mammary gland by one or more mastitis pathogens such as 
Staphylococcus aureus, Streptococcus uberis, and Escherichia coli.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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